305 related articles for article (PubMed ID: 16691370)
1. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells.
Gao C; Guo H; Downey L; Marroquin C; Wei J; Kuo PC
Carcinogenesis; 2003 Dec; 24(12):1871-8. PubMed ID: 12949055
[TBL] [Abstract][Full Text] [Related]
5. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.
Desai B; Ma T; Zhu J; Chellaiah MA
J Cell Biochem; 2009 Sep; 108(1):272-84. PubMed ID: 19582779
[TBL] [Abstract][Full Text] [Related]
7. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met).
Tuck AB; Elliott BE; Hota C; Tremblay E; Chambers AF
J Cell Biochem; 2000 Jun; 78(3):465-75. PubMed ID: 10861844
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
10. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.
Takazoe K; Foti R; Tesch GH; Hurst LA; Lan HY; Atkins RC; Nikolic-Paterson DJ
Clin Exp Immunol; 2000 Sep; 121(3):523-32. PubMed ID: 10971520
[TBL] [Abstract][Full Text] [Related]
12. Restoration of CD44S in non-small cell lung cancer cells enhanced their susceptibility to the macrophage cytotoxicity.
Takahashi K; Takahashi F; Hirama M; Tanabe KK; Fukuchi Y
Lung Cancer; 2003 Aug; 41(2):145-53. PubMed ID: 12871777
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.
Phillips RJ; Helbig KJ; Van der Hoek KH; Seth D; Beard MR
World J Gastroenterol; 2012 Jul; 18(26):3389-99. PubMed ID: 22807608
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
Marroquin CE; Downey L; Guo H; Kuo PC
Immunol Lett; 2004 Aug; 95(1):109-12. PubMed ID: 15325806
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
16. CD44 variant exons in leukemia and lymphoma.
Akisik E; Bavbek S; Dalay N
Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
[TBL] [Abstract][Full Text] [Related]
17. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.
Cook AC; Chambers AF; Turley EA; Tuck AB
J Biol Chem; 2006 Aug; 281(34):24381-9. PubMed ID: 16807238
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
